Metropolitan Life Insurance Company (MetLife)’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,256
| Closed | -$193K | – | 250 |
|
|
2024
Q1 | $193K | Sell |
6,256
-382
| -6% | -$11.8K | 0.01% | 731 |
|
|
2023
Q4 | $268K | Hold |
6,638
| – | – | 0.01% | 611 |
|
|
2023
Q3 | $175K | Buy |
6,638
+380
| +6% | +$10K | 0.01% | 743 |
|
|
2023
Q2 | $108K | Buy |
6,258
+372
| +6% | +$6.4K | 0.01% | 982 |
|
|
2023
Q1 | $97.6K | Sell |
5,886
-902
| -13% | -$15K | 0.01% | 1005 |
|
|
2022
Q4 | $51.7K | Hold |
6,788
| – | – | ﹤0.01% | 1449 |
|
|
2022
Q3 | $67.5K | Hold |
6,788
| – | – | ﹤0.01% | 1258 |
|
|
2022
Q2 | $61.6K | Hold |
6,788
| – | – | ﹤0.01% | 1363 |
|
|
2022
Q1 | $68.9K | Sell |
6,788
-20,117
| -75% | -$204K | ﹤0.01% | 1412 |
|
|
2021
Q4 | $449K | Sell |
26,905
-1,560
| -5% | -$26K | 0.01% | 1518 |
|
|
2021
Q3 | $1.33M | Sell |
28,465
-879
| -3% | -$41.2K | 0.02% | 768 |
|
|
2021
Q2 | $1.79M | Buy |
29,344
+3,861
| +15% | +$235K | 0.03% | 583 |
|
|
2021
Q1 | $1.57M | Buy |
25,483
+4,478
| +21% | +$276K | 0.02% | 656 |
|
|
2020
Q4 | $1.49M | Hold |
21,005
| – | – | 0.02% | 625 |
|
|
2020
Q3 | $788K | Sell |
21,005
-1,692
| -7% | -$63.5K | 0.01% | 888 |
|
|
2020
Q2 | $740K | Hold |
22,697
| – | – | 0.01% | 931 |
|
|
2020
Q1 | $658K | Buy |
22,697
+15,203
| +203% | +$441K | 0.01% | 903 |
|
|
2019
Q4 | $263K | Sell |
7,494
-3,336
| -31% | -$117K | ﹤0.01% | 1732 |
|
|
2019
Q3 | $233K | Buy |
+10,830
| New | +$233K | ﹤0.01% | 1775 |
|